NASDAQ:CTMX - CytomX Therapeutics News Headlines

$10.40
+0.17 (+1.66 %)
(As of 06/16/2019 07:37 AM ET)
Today's Range
$10.04
Now: $10.40
$10.54
50-Day Range
$9.35
MA: $10.39
$11.36
52-Week Range
$8.94
Now: $10.40
$27.20
Volume300,960 shs
Average Volume300,958 shs
Market Capitalization$471.22 million
P/E RatioN/A
Dividend YieldN/A
Beta0.51

Headlines

CytomX Therapeutics (NASDAQ CTMX) News Headlines

Source:
DateHeadline
CytomX Therapeutics (CTMX) Presents At Goldman Sachs 40th Annual Global Healthcare Conference - SlideshowCytomX Therapeutics (CTMX) Presents At Goldman Sachs 40th Annual Global Healthcare Conference - Slideshow
seekingalpha.com - June 15 at 12:38 AM
Mizuho Initiates Coverage on CytomX Therapeutics (NASDAQ:CTMX)Mizuho Initiates Coverage on CytomX Therapeutics (NASDAQ:CTMX)
www.americanbankingnews.com - June 12 at 6:30 PM
CytomX Therapeutics Inc (NASDAQ:CTMX) Receives Average Recommendation of "Buy" from AnalystsCytomX Therapeutics Inc (NASDAQ:CTMX) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - June 11 at 4:34 PM
CytomX Therapeutics Inc (NASDAQ:CTMX) Expected to Post Quarterly Sales of $15.11 MillionCytomX Therapeutics Inc (NASDAQ:CTMX) Expected to Post Quarterly Sales of $15.11 Million
www.americanbankingnews.com - June 10 at 1:26 AM
 Brokerages Anticipate CytomX Therapeutics Inc (NASDAQ:CTMX) to Post -$0.55 EPS Brokerages Anticipate CytomX Therapeutics Inc (NASDAQ:CTMX) to Post -$0.55 EPS
www.americanbankingnews.com - June 8 at 8:10 PM
CytomX Therapeutics (CTMX) Presents At 2019 Jefferies Global Healthcare Conference - SlideshowCytomX Therapeutics (CTMX) Presents At 2019 Jefferies Global Healthcare Conference - Slideshow
seekingalpha.com - June 6 at 7:12 PM
Cantor Fitzgerald Reaffirms "Overweight" Rating for CytomX Therapeutics (CTMX)Cantor Fitzgerald Reaffirms "Overweight" Rating for CytomX Therapeutics (CTMX)
www.americanbankingnews.com - June 3 at 7:55 AM
CytomX Therapeutics Provides Update on Anti-PD-L1 Probody CX-072 at 2019 ASCO Annual MeetingCytomX Therapeutics Provides Update on Anti-PD-L1 Probody CX-072 at 2019 ASCO Annual Meeting
finance.yahoo.com - June 1 at 5:41 PM
CytomX Therapeutics to Present at Upcoming Healthcare ConferencesCytomX Therapeutics to Present at Upcoming Healthcare Conferences
finance.yahoo.com - May 28 at 8:16 AM
CytomX Therapeutics Announces Presentations at 2019 ASCO Annual MeetingCytomX Therapeutics Announces Presentations at 2019 ASCO Annual Meeting
finance.yahoo.com - May 15 at 9:42 PM
CytomX Therapeutics, Inc. (CTMX) Q1 2019 Earnings Call TranscriptCytomX Therapeutics, Inc. (CTMX) Q1 2019 Earnings Call Transcript
finance.yahoo.com - May 13 at 7:58 PM
CytomX Therapeutics, Inc. (CTMX) CEO Sean McCarthy on Q1 2019 Results - Earnings Call TranscriptCytomX Therapeutics, Inc. (CTMX) CEO Sean McCarthy on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 10 at 8:21 AM
Edited Transcript of CTMX earnings conference call or presentation 9-May-19 9:00pm GMTEdited Transcript of CTMX earnings conference call or presentation 9-May-19 9:00pm GMT
finance.yahoo.com - May 10 at 8:21 AM
CytomX Therapeutics Announces First Quarter 2019 Financial ResultsCytomX Therapeutics Announces First Quarter 2019 Financial Results
www.marketwatch.com - May 9 at 7:48 PM
CytomX Therapeutics (CTMX) Reports Q1 Loss, Tops Revenue EstimatesCytomX Therapeutics (CTMX) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 9 at 7:48 PM
Were Hedge Funds Right About Dumping CytomX Therapeutics, Inc. (CTMX)?Were Hedge Funds Right About Dumping CytomX Therapeutics, Inc. (CTMX)?
finance.yahoo.com - May 9 at 7:48 PM
CytomX Therapeutics to Present at the Bank of America Merrill Lynch 2019 Health Care ConferenceCytomX Therapeutics to Present at the Bank of America Merrill Lynch 2019 Health Care Conference
finance.yahoo.com - May 7 at 8:22 AM
CytomX Therapeutics to Announce First Quarter 2019 Financial ResultsCytomX Therapeutics to Announce First Quarter 2019 Financial Results
finance.yahoo.com - May 2 at 8:21 AM
Turning Point IPO: Targeting A Massive MarketTurning Point IPO: Targeting A Massive Market
seekingalpha.com - April 16 at 8:27 AM
What Kind Of Investor Owns Most Of CytomX Therapeutics, Inc. (NASDAQ:CTMX)?What Kind Of Investor Owns Most Of CytomX Therapeutics, Inc. (NASDAQ:CTMX)?
finance.yahoo.com - April 11 at 7:47 PM
CytomX amends license agreement with University of CaliforniaCytomX amends license agreement with University of California
seekingalpha.com - April 8 at 7:53 PM
AACR 2019 Presentations Highlight CX-2009, a First-In-Class Probody Drug Conjugate Targeting Novel Tumor Antigen, CD166AACR 2019 Presentations Highlight CX-2009, a First-In-Class Probody Drug Conjugate Targeting Novel Tumor Antigen, CD166
finance.yahoo.com - April 2 at 8:36 AM
CytomX Therapeutics Announces Transition of Chief Financial OfficerCytomX Therapeutics Announces Transition of Chief Financial Officer
finance.yahoo.com - March 25 at 7:38 PM
CytomX Therapeutics IncCytomX Therapeutics Inc
www.bloomberg.com - March 19 at 7:49 PM
Daily Biotech Pulse: Tonix Gets European Patent, EC Nod For Roche, Insys Earnings - BenzingaDaily Biotech Pulse: Tonix Gets European Patent, EC Nod For Roche, Insys Earnings - Benzinga
www.benzinga.com - March 8 at 8:20 AM
The Daily Biotech Pulse: Allergans Depression Drug Flunks Late-Stage Trial, Apellis Offering, ShockWave Medical IPO - BenzingaThe Daily Biotech Pulse: Allergan's Depression Drug Flunks Late-Stage Trial, Apellis Offering, ShockWave Medical IPO - Benzinga
www.benzinga.com - March 7 at 8:30 AM
Have Insiders Been Buying CytomX Therapeutics, Inc. (NASDAQ:CTMX) Shares?Have Insiders Been Buying CytomX Therapeutics, Inc. (NASDAQ:CTMX) Shares?
finance.yahoo.com - March 6 at 7:37 PM
Edited Transcript of CTMX earnings conference call or presentation 27-Feb-19 10:00pm GMTEdited Transcript of CTMX earnings conference call or presentation 27-Feb-19 10:00pm GMT
finance.yahoo.com - February 28 at 7:07 PM
CytomX Therapeutics (CTMX) CEO Sean McCarthy on Q4 2018 Results - Earnings Call TranscriptCytomX Therapeutics' (CTMX) CEO Sean McCarthy on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - February 28 at 8:21 AM
CytomX Therapeutics Announces Full-Year 2018 Financial ResultsCytomX Therapeutics Announces Full-Year 2018 Financial Results
finance.yahoo.com - February 27 at 7:24 PM
CytomX Therapeutics Announces Presentations at the American Association for Cancer Research Annual Meeting 2019CytomX Therapeutics Announces Presentations at the American Association for Cancer Research Annual Meeting 2019
finance.yahoo.com - February 27 at 7:24 PM
CytomX Therapeutics Inc.CytomX Therapeutics Inc.
www.barrons.com - February 26 at 6:45 PM
CytomX down 30% on negative pipeline developmentsCytomX down 30% on negative pipeline developments
seekingalpha.com - February 26 at 6:45 PM
CytomX Therapeutics 2019 Research and Development Day Highlights Clinical Data from Lead Programs and the Broad Potential of Probody™ Therapeutic Platform - GlobeNewswireCytomX Therapeutics 2019 Research and Development Day Highlights Clinical Data from Lead Programs and the Broad Potential of Probody™ Therapeutic Platform - GlobeNewswire
globenewswire.com - February 26 at 8:18 AM
CytomX Therapeutics 2019 Research and Development Day Highlights Clinical Data from Lead Programs and the Broad Potential of Probody™ Therapeutic PlatformCytomX Therapeutics 2019 Research and Development Day Highlights Clinical Data from Lead Programs and the Broad Potential of Probody™ Therapeutic Platform
finance.yahoo.com - February 26 at 8:18 AM
Analysts Estimate CytomX Therapeutics (CTMX) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate CytomX Therapeutics (CTMX) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - February 20 at 6:54 PM
Analysis: Positioning to Benefit within Jacobs Engineering Group, Ares Capital, CytomX Therapeutics, FuelCell Energy, Timken, and Farmland Partners — Research Highlights Growth, Revenue, and Consolidated ResultsAnalysis: Positioning to Benefit within Jacobs Engineering Group, Ares Capital, CytomX Therapeutics, FuelCell Energy, Timken, and Farmland Partners — Research Highlights Growth, Revenue, and Consolidated Results
finance.yahoo.com - February 20 at 8:21 AM
CytomX Therapeutics to Announce Full-Year 2018 Financial Results and Host Webcast Conference Call - GlobeNewswireCytomX Therapeutics to Announce Full-Year 2018 Financial Results and Host Webcast Conference Call - GlobeNewswire
globenewswire.com - February 14 at 6:27 PM
CytomX Therapeutics to Announce Full-Year 2018 Financial Results and Host Webcast Conference CallCytomX Therapeutics to Announce Full-Year 2018 Financial Results and Host Webcast Conference Call
finance.yahoo.com - February 14 at 6:27 PM
CytomX Therapeutics announces senior management hiresCytomX Therapeutics announces senior management hires
seekingalpha.com - February 5 at 6:33 PM
CytomX Therapeutics Announces Senior Management AppointmentsCytomX Therapeutics Announces Senior Management Appointments
finance.yahoo.com - February 5 at 6:33 PM
CytomX Therapeutics to Host Research and Development Day on February 26, 2019CytomX Therapeutics to Host Research and Development Day on February 26, 2019
finance.yahoo.com - January 30 at 8:11 AM
Are CytomX Therapeutics, Inc.’s (NASDAQ:CTMX) Interest Costs Too High?Are CytomX Therapeutics, Inc.’s (NASDAQ:CTMX) Interest Costs Too High?
finance.yahoo.com - January 22 at 6:27 PM
CytomX Therapeutics Shares March Higher, Can It Continue?CytomX Therapeutics Shares March Higher, Can It Continue?
www.zacks.com - January 16 at 8:17 AM
CytomX Therapeutics Announces Technology Acquisition From Agensys, Inc., an Affiliate of Astellas Pharma Inc.CytomX Therapeutics Announces Technology Acquisition From Agensys, Inc., an Affiliate of Astellas Pharma Inc.
finance.yahoo.com - January 7 at 8:12 AM
CytomX Therapeutics Announces Changes to its Board of DirectorsCytomX Therapeutics Announces Changes to its Board of Directors
finance.yahoo.com - December 20 at 8:16 AM
Is CytomX Therapeutics, Inc. (CTMX) A Good Stock To Buy?Is CytomX Therapeutics, Inc. (CTMX) A Good Stock To Buy?
finance.yahoo.com - December 17 at 8:14 AM
Consolidated Research: 2018 Summary Expectations for CarGurus, ARMOUR Residential REIT, Braskem S.AConsolidated Research: 2018 Summary Expectations for CarGurus, ARMOUR Residential REIT, Braskem S.A
www.nasdaq.com - November 27 at 8:29 AM
Consolidated Research: 2018 Summary Expectations for CarGurus, ARMOUR Residential REIT, Braskem S.A, HCI Group, Kimball Electronics, and CytomX Therapeutics — Fundamental Analysis, Key Performance IndicationsConsolidated Research: 2018 Summary Expectations for CarGurus, ARMOUR Residential REIT, Braskem S.A, HCI Group, Kimball Electronics, and CytomX Therapeutics — Fundamental Analysis, Key Performance Indications
finance.yahoo.com - November 27 at 8:29 AM
Should You Worry About CytomX Therapeutics Inc’s (NASDAQ:CTMX) CEO Pay?Should You Worry About CytomX Therapeutics Inc’s (NASDAQ:CTMX) CEO Pay?
finance.yahoo.com - November 20 at 5:22 PM
This page was last updated on 6/16/2019 by MarketBeat.com Staff

Featured Article: Straddles

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel